Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis

Hatem Ali(National Research Centre), Ahmed Halawa(University of Liverpool), Tibor Fülöp(Medical University of South Carolina), Mahmoud Mohamed(University of Tennessee Health Science Center), Ajay Sharma(Paras Hospitals)
American Journal of Nephrology
January 1, 2021
Cited by 8


Related Papers